Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Survey of Ophthalmology|February 18, 2019
Bilateral epibulbar pseudorheumatoid nodulosis with a review of ocular adnexal palisading granulomasMarisa G Tieger, Frederick A Jakobiec, Natalie Wolkow, et al.
Natural Products and Bioprospecting|March 25, 2014
Morphological Effects of Natural Products on Schizosaccharomyces pombe Measured by Imaging Flow CytometryJoel Heisler, Lindsay Elvir, Farah Barnouti, et al.
Journal of Microbiology & Biology Education|July 19, 2019
One Early Course-Based Undergraduate Research Experience Produces Sustainable Knowledge Gains, but only Transient Perception GainsTom D Wolkow, Jill Jenkins, Lisa Durrenberger, et al.
Plos One|January 24, 2015
Sleep restriction during simulated wildfire suppression: effect on physical task performanceGrace Vincent, Sally A Ferguson, Jacqueline Tran, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 20, 2018
Multiple Eyelid Cysts (Apocrine and Eccrine Hidrocystomas, Trichilemmal Cyst, and Hybrid Cyst) in a Patient With a ProlactinomaLina Ma, Frederick A Jakobiec, Natalie Wolkow, et al.
American Journal of Ophthalmology|December 2, 2017
Osseous and Adipocytic Differentiations in the Intraocular Lens and VitreousFrederick A Jakobiec, Lina Ma, Natalie Wolkow, et al.
The Journal of Clinical Psychiatry|February 24, 2001
Sertraline treatment of panic disorder: response in patients at risk for poor outcomeM H Pollack, M H Rapaport, C M Clary, et al.
Journal of Clinical Psychopharmacology|February 24, 2001
Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepinesM H Rapaport, M H Pollack, C M Clary, et al.
Molecular Biology Research Communications|January 31, 2022
Fission yeast Ase1<sup>PRC1</sup> is required for the G<sub>2</sub>-microtubule damage responseRose M Doss, Sindi Xhunga, Dorothy Klimczak, et al.
American Journal of Ophthalmology|July 31, 2020
High Expression of Programmed Death Ligand 1 and Programmed Death Ligand 2 in Ophthalmic Sebaceous Carcinoma: The Case for a Clinical Trial of Checkpoint InhibitorsNatalie Wolkow, Frederick A Jakobiec, Amir H Afrogheh, et al.
Pageof 26